Par Drugs and Chemicals Limited — Others, 15-02-2025: Copy of Newspaper Publication

Par Drugs and Chemicals Limited has announced a board meeting on February 14, 2025, to approve the financial results for the quarter and nine months ended December 31, 2024. The company reported a total income from operations of ₹33.00 crore, a net profit of ₹0.98 crore before tax, and earnings per share (EPS) of ₹0.33 for the quarter.

The significant increase in total income compared to the previous year suggests strong operational performance, likely boosting investor confidence. However, the fluctuating net profits indicate potential volatility in earnings, which could be a risk for investors. Overall, the results reflect a positive momentum in the company's core operations, signaling opportunities for growth.